Glycobiology Market Size for Pharmaceutical and Biotechnology Companies, By Region

According to the new market research report Glycomics/Glycobiology Market by Product (Enzymes (Glycosyltransferase, Glycosidase), Instruments (HPLS, Mass Spectrometry, MALDITOF), Kits & Reagents (Glycoproteins)), Application (Diagnostic, Drug Discovery, Oncology), End User – Global Forecast to 2021, published by MarketsandMarkets™, provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the Glycomics/Glycobiology market along with estimates and forecasts of the revenue and share analysis.

Get 10% Free Discount on Customization: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=132685525

The global glycobiology market is poised to reach USD 1,211.4 million by 2021 from USD 649.5 million in 2016, at a CAGR of 13.3%. Glycomics products are widely used for the analysis of cell surface markers, which can act as diagnostic or therapeutic targets. Factors such as increasing government and private funding for glycomics and proteomics research and growing R&D expenditure by pharmaceutical and biotechnology companies are the key drivers for the growth of the market.

The glycomics/glycobiology market is dominated by a few major players, with the top five players accounting for a majority of the market share. The top four players for glycomics enzymes, kits, and reagents have a combined market share of about 75.2% and for glycomics instruments have a combined market share of about 76.0%.

On the basis of region, the market is segmented into North America, Asia, Europe, and RoW. The Asian market is estimated to grow at the highest CAGR during the forecast period. This growth is mainly attributed to the increasing commercialization of R&D by pharmaceutical and biotechnology companies, growing demand for personalized medicine, and rising importance of companion diagnostics. Over the past few years, the overall Asian region has witnessed growth in the glycomics market as North American and European pharmaceutical drug manufacturers find it cost-effective to outsource their glycomics-based work to Asian manufacturers or set up their manufacturing facilities in Asian countries.

Browse and in-depth TOC on “Glycobiology Market”

158 – Pages

91 – Tables     

32 – Figures

To Get Free Sample Report:  https://www.marketsandmarkets.com/requestsampleNew.asp?id=132685525

There is a high degree of rivalry amongst market players, which keeps the market highly competitive. The top players in glycomics market are large and well-established players, who enjoy strong brand loyalty. New entrants in this market have to compete with existing players and differentiate themselves and their product offerings; this will require high capital, R&D, and manufacturing investments. Additionally, R&D in this market is a very time-consuming process and needs heavy investments in terms of human efforts and time as well. These factors are restraining the entry of new players, and as such are expected to restrain the growth potential of this market.

The key players in the glycobiology market include Agilent Technologies (U.S.), Bruker Corporation (U.S.), Danaher Corporation (U.S.), New England Biolabs (U.S.), ProZyme, Inc. (U.S.), Shimadzu Corporation (Japan), Merck KGaA (Germany), Takara Bio, Inc. (Japan), Thermo Fisher Scientific (U.S.), and Waters Corporation (U.S.).

Speak to Analyst @ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=132685525

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Shelly Singh

MarketsandMarkets™ INC.630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: 1-888-600-6441

Email: sales@marketsandmarkets.com

Research Insight: https://www.marketsandmarkets.com/ResearchInsight/glycobiology-market.asp

Visit Our Website: https://www.marketsandmarkets.com

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.